ROIVANT SCIENCES LTD. Disposal Group, Including Discontinued Operation, Liabilities, Current
ROIVANT SCIENCES LTD. (ROIV) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $0 as of 2025-03-31, per its 10-K filed 2025-05-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2025-05-29
- 2025-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
- 2024-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $401.21M.
- 2024-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $110.41M.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-05-29 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-10 |
| 2024-09-30 | $401.21M 10-Q · filed 2024-11-12 |
| 2024-03-31 | $110.41M 10-K · filed 2025-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |